Russia's Pharmstandard allocates $12 million for its Kursk plant modernisation
This article was originally published in Scrip
Executive Summary
Russia's largest pharmaceutical manufacturer, Pharmstandard, has pledged to invest Rb330 million ($12 million) into the modernisation of its facility in Kursk, a city 530 kilometres south-west of Moscow.